Transcription of Allergen immunotherapy: A practice parameter third update
{{id}} {{{paragraph}}}
Task force reportAllergen immunotherapy: A practice parameter third updateChief Editors: Linda Cox, MD, Harold Nelson, MD, and Richard Lockey, MDWorkgroup Contributors: Christopher Calabria, MD, Thomas Chacko, MD, Ira Finegold, MD, Michael Nelson, MD, PhD,and Richard Weber, MDTask Force Reviewers: David I. Bernstein, MD, Joann Blessing-Moore, MD, David A. Khan, MD, David M. Lang, MD,Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher Randolph, MD, Diane E. Schuller, MD,Sheldon L. Spector, MD, Stephen Tilles, MD, and Dana Wallace, MDKeywords: allergy immunotherapy, subcutaneous immunotherapy,sublingual immunotherapy, allergic rhinitis, asthma, Hymenoptera,atopic dermatitis, anaphylaxis, epinephrine,b-blockers, angioten-sin-converting enzyme inhibitor, epicutaneous immunotherapy, in-tralymphatic immunotherapy, nasal imm
Cleveland Clinic Foundation Cleveland, Ohio Richard A. Nicklas, MD Department of Medicine George Washington Medical Center Washington, DC John Oppenheimer, MD Department of Internal Medicine New Jersey Medical School Pulmonary and Allergy Associates Morristown, New Jersey Jay M. Portnoy, MD Section of Allergy, Asthma & Immunology The Children ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}